|Bid||57.00 x 900|
|Ask||62.00 x 800|
|Day's Range||59.41 - 63.68|
|52 Week Range||8.51 - 66.24|
|Beta (5Y Monthly)||3.02|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.50|
Jim Cramer shares insights about buying General Electric, Arcturus vaccine, and Roblox filing to go public.
Messenger RNA (mRNA) coronavirus vaccine candidates now appear to be batting two for two. Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced great interim efficacy results for their experimental mRNA COVID-19 vaccine last week. Are there other biotech stocks with mRNA vaccine programs that could also be winners?
Promising vaccine news lifted both companies’ stocks on hopes it will validate mRNA technology and speed other products to market.